CBD Company Caliper Foods Partners With Colorado State University on Placebo-Controlled Clinical Research Study That Also Examined Liver Function
DENVER — Caliper Foods, the pioneer of fast-acting, scientifically backed, water soluble cannabinoids, recently completed a clinical research study in partnership with Colorado State University in which findings showed that formulation design makes a significant difference in pharmacokinetics—the rate and amount of CBD absorbed into the body. The study also found that consumption of food significantly increased pharmacokinetic absorption of Caliper Foods’ proprietary formulation of water-soluble cannabidiol (CBD).
“These findings further the industry’s understanding about how cannabinoids are being absorbed and metabolized by the body, which allows cannabis brands to create products that deliver predictable, efficacious doses to allow consumers to get the intended health benefits of CBD,” said Dr. Chris Bell, a study co-author and Director of the Integrative Biology Lab at CSU.
Five different 30 milligram CBD formulations were clinically tested, with Caliper Foods’ water-soluble CBD exhibiting 282% to 434% greater absorption than oil-based CBD formulations. Additionally, the 30mg dose of CBD was evaluated for impact to the liver. The study authors concluded that consuming Caliper Foods’ water-soluble CBD with food “increases systemic availability by 2.2X and low-dose CBD probably does not represent a risk to normal liver function.”
“Caliper Foods seeks to advance cannabinoid research, and understanding the pharmacokinetics helps researchers design studies that build from this clinical research and use formulations with known absorption patterns,” said Keith Woelfel, Director of Research Development at Caliper Foods. “For example, pharmacokinetic data from our specific water-soluble formulations have been used to design and conduct research examining CBD effects on autism, alcohol cravings and enhanced sports performance. I look forward to Caliper Foods’ continued role in these and other health-related research endeavors.”
More information about this clinical study, published in the science journal Nutrients, can be found at mdpi.com.
About Caliper Foods
Founded in 2014, Caliper Foods is a functional foods company with deep expertise in the processing, manufacture, and commercialization of cannabinoid-infused food, beverage, and supplement products. Built on the idea that cannabinoids represent a new category of functional ingredients, Caliper Foods’ operations utilize common manufacturing practices, formulations, and quality systems designed to meet the standards of the nation’s largest CPG brands and retailers. Caliper Foods also invests heavily in published, peer-reviewed research with independent university partners to clinically validate the superior pharmacokinetic properties of its branded ingredients and consumer products alike. For more information, please visit www.caliperfoods.com.
- Commentary: It’s time for Biden to keep his promises on cannabis
Paul Armentano, the deputy director of the National Organization for the Reform of Marijuana Laws (NORML), calls on President Joe Biden to live up to the pledges made during his campaign regarding cannabis legalization. - Unofficial totals show Missouri cannabis legalization initiative short
An initiative to legalize recreational marijuana use in Missouri will need help if it is going to be on the November ballot. Reports from every county in the state show the petition is short of its goal in two of the six congressional districts needed to qualify for the ballot. - Fate of Missouri cannabis initiative unclear as signature count continues
Whether Missouri voters will get a chance to legalize recreational marijuana in November is still in question. The latest incomplete tabulations show the Legal Missouri 2022 initiative is short of the necessary signatures in four of the six Congressional districts necessary to make the ballot. - ACLU of NV suit to deschedule cannabis statewide survives challenge
A legal effort by the ACLU of Nevada to force the Nevada Board of Pharmacy to remove cannabis from its Schedule 1 of controlled substances will proceed, Clark County Judge Joe Hardy ruled Wednesday when he denied the board’s motion to dismiss the ACLU’s lawsuit. - Advocates, parents ‘beg’ Nebraskans to seek out and sign petition to legalize medical cannabis
Advocates for legalizing medical marijuana switched Wednesday from urging Nebraskans to sign their petition to begging them as a July 7 deadline looms to submit signatures to qualify for the ballot in November. - Iowans launch cannabis reform campaign aimed at showing public support
Robert “Lewy” Lewis of Windsor Heights has been in pain since 1974, when he had spinal surgery at the age of 21. To repair a blockage in his spine, surgeons removed eight inches of his vertebrae and then sewed them back on, using about 300 steel stitches. - Big Apple Cannabis: CWCB Returns to New York City for Eighth Year
“No one seems to have gotten it right.” Mayor Eric Adams told a Friday afternoon crowd, of legal cannabis in America. “This is our chance to get it right.” New York City’s mayor addressed attendees of the 2022 Cannabis World Congress & Business Expo (CWCBExpo) on the second day of the three-day event. Adams stressed the social equity focus of New York’s cannabis program. - Nebraska medical cannabis backers file legal challenge to petition process
Supporters of medical marijuana in Nebraska have launched a legal challenge to the state’s requirement that 5% of registered voters in at least 38 counties sign a petition to get the measure before voters on the ballot. - N.J. lawmakers seek to curb cannabis use
As New Jersey nears the end of its first month of legal recreational marijuana sales, lawmakers have introduced a series of bills aimed at restricting what types of workers can use cannabis off the job. - Missouri House votes to require disclosure of medical cannabis ownership records
The Missouri House voted overwhelmingly Tuesday to require state regulators to disclose ownership information for businesses granted medical marijuana licenses that the state has withheld from public view.